Investment
Features
FeesSafety
Academy
More
Pluang+

OS Therapies aligns with FDA, MHRA, EMA on Phase 3 trial design and joins Project Orbis for faster cancer drug approval

Market News
17 Sep 2026
Newsfile Corp
View Source
Bullish
OS Therapies aligns with FDA, MHRA, EMA on Phase 3 trial design and joins Project Orbis for faster cancer drug approval

OS Therapies has reached agreement with the FDA, MHRA, and EMA on an adaptive design for its Phase 3 trial of OST-HER2, a gene-edited cancer immunotherapy targeting metastatic osteosarcoma. The company will start this trial in late 2026 and plans a key FDA meeting after submitting 3-year survival data. OS Therapies also accepted MHRA's request to lead its participation in Project Orbis, a global initiative to speed up oncology drug approvals through coordinated regulatory reviews. OST-HER2 holds multiple designations including Orphan Drug and Fast Track, and if approved, OS Therapies could receive a valuable Priority Review Voucher to sell. This alignment and Project Orbis involvement aim to accelerate OST-HER2's availability in the US, UK, and Europe.

OS Therapies' recent regulatory progress is provided here with a snapshot of the Health sector on Pluang as of Sep 17, 2026 17:02 WIB: Among 91 priced US health stocks, 59 rose and 27 fell. Ascendis Pharma (ASND) traded at USD 239.50 with a 3.31% decline and a strong 91% sell order activity, contrasting with Sana Biotechnology (SANA) at USD 3.00 gaining 2.74% but seeing 86% sell orders. American Well Corp (AMWL) rose 2.03% to USD 13.60, holding the longest typical Pluang hold time of 61 days in this group.

More News

New 'BadEngram' attack exposes hidden risks in open-weight AI models' memory components

New 'BadEngram' attack exposes hidden risks in open-weight AI models' memory components

Researchers from Pillar Security and Fujitsu revealed 'BadEngram,' a stealthy supply-chain attack targeting the gated memory components in open-weight AI models like Qwen3.8-Flash-Next and DeepSeek-V4.1-Flash. This attack implants a hidden backdoor b...

Market News
Bearish
23 minutes ago
Alm. Brand A/S buys back 1.07 million shares in latest week, holding 3.49% of total shares.

Alm. Brand A/S buys back 1.07 million shares in latest week, holding 3.49% of total shares.

Alm. Brand A/S continued its share buyback program from October 6 to 12, 2026, purchasing 1,067,445 shares at an average price of DKK 16.41 per share. This brings the total shares bought under the program to 16,272,795, with a cumulative spend of abo...

Company Fundamentals
Neutral
23 minutes ago
Michelin reports total voting rights and shares as of September 30, 2026, including treasury shares.

Michelin reports total voting rights and shares as of September 30, 2026, including treasury shares.

Michelin has officially declared the total number of voting rights and shares composing its capital as of September 30, 2026. The company reports 687,606,419 shares outstanding, with a theoretical total of 976,500,156 voting rights and 958,851,942 ex...

Company Fundamentals
Neutral
23 minutes ago
Michelin reports total voting rights and shares as of September 30, 2026

Michelin reports total voting rights and shares as of September 30, 2026

Michelin disclosed the total number of its shares and voting rights as of September 30, 2026. The company has 687,606,419 shares and 958,851,942 voting rights, accounting for 17,648,214 treasury shares. This disclosure is part of regulatory complianc...

Company Fundamentals
Neutral
23 minutes ago
US Rental Business Census 2026 counts 128,188 rental listings, revealing state-by-state rental market insights.

US Rental Business Census 2026 counts 128,188 rental listings, revealing state-by-state rental market insights.

The US Rental Business Census 2026 by Reservety reports 128,188 rental business listings across 12 categories in all US states and D.C., identifying about 114,235 unique businesses with 98,123 independent operators. Wyoming leads with the highest ren...

Market News
Neutral
23 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App